Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Topical bovine thrombin and adverse events: a review of the literature.

Clark J, Crean S, Reynolds MW.

Curr Med Res Opin. 2008 Jul;24(7):2071-87. doi: 10.1185/03007990802186417 . Epub 2008 Jun 11. Review.

PMID:
18549663
2.

Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.

Clark JA, Humphries JE, Crean S, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):107-14. doi: 10.1002/pds.1874. Review.

PMID:
20014051
3.

A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.

Ofosu FA, Crean S, Reynolds MW.

Clin Ther. 2009 Apr;31(4):679-91. doi: 10.1016/j.clinthera.2009.04.021. Review.

PMID:
19446142
4.

Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.

Su Z, Izumi T, Thames EH, Lawson JH, Ortel TL.

J Lab Clin Med. 2002 Jun;139(6):349-56.

PMID:
12066133
5.

Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.

Rodgers GM.

J Pediatr Hematol Oncol. 2011 Mar;33(2):86-8. doi: 10.1097/MPH.0b013e3181ff0e43. Review.

PMID:
21228719
6.

A review of three stand-alone topical thrombins for surgical hemostasis.

Cheng CM, Meyer-Massetti C, Kayser SR.

Clin Ther. 2009 Jan;31(1):32-41. doi: 10.1016/j.clinthera.2009.01.005. Review.

PMID:
19243705
7.

A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.

Singla NK, Ballard JL, Moneta G, Randleman CD Jr, Renkens KL, Alexander WA.

J Am Coll Surg. 2009 Jul;209(1):68-74. doi: 10.1016/j.jamcollsurg.2009.03.016. Epub 2009 May 28.

PMID:
19651065
8.

Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.

Adams JD, Jones S, Brost BC.

J Reprod Med. 2001 Oct;46(10):909-12.

PMID:
11725736
9.

Immune-mediated coagulopathy: a case report.

Naoum JJ.

Pharmacotherapy. 2009 Jul;29(7 Pt 2):13S-7S. doi: 10.1592/phco.29.pt2.13S.

PMID:
19558280
10.

Persistence of antibodies to the topical hemostat bovine thrombin.

Randleman CD Jr, Singla NK, Renkens KL, Souza S, Pribble JP, Alexander WA.

J Am Coll Surg. 2010 Dec;211(6):798-803. doi: 10.1016/j.jamcollsurg.2010.07.023. Epub 2010 Oct 25.

PMID:
20980172
11.

Bovine thrombin: history, use, and risk in the surgical patient.

Diesen DL, Lawson JH.

Vascular. 2008 Mar-Apr;16 Suppl 1:S29-36. Review. Erratum in: Vascular. 2009 May-Jun;17(3):181.

PMID:
18544303
12.

Anaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis population.

Wai Y, Tsui V, Peng Z, Richardson R, Oreopoulos D, Tarlo SM.

Clin Exp Allergy. 2003 Dec;33(12):1730-4.

PMID:
14656362
13.

Risk and clinical significance of developing antibodies induced by topical thrombin preparations.

Dorion RP, Hamati HF, Landis B, Frey C, Heydt D, Carey D.

Arch Pathol Lab Med. 1998 Oct;122(10):887-94.

PMID:
9786349
14.

Topical thrombins: benefits and risks.

Lomax C, Traub O.

Pharmacotherapy. 2009 Jul;29(7 Pt 2):8S-12S. doi: 10.1592/phco.29.pt2.8S.

PMID:
19558279
15.

Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose.

Schoenecker JG, Hauck RK, Mercer MC, Parker W, Lawson JH.

J Clin Immunol. 2000 Nov;20(6):434-44.

PMID:
11202233
16.

Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.

Vannorsdall MD, Arkel YS, Ku DH, Lucas FL, Himmelfarb J.

Kidney Int. 2003 Aug;64(2):690-6.

17.

Topical recombinant human thrombin in surgical hemostasis.

Bowman LJ, Anderson CD, Chapman WC.

Semin Thromb Hemost. 2010 Jul;36(5):477-84. doi: 10.1055/s-0030-1255441. Epub 2010 Jul 14. Review.

PMID:
20632245
18.

The educational effects of portfolios on undergraduate student learning: a Best Evidence Medical Education (BEME) systematic review. BEME Guide No. 11.

Buckley S, Coleman J, Davison I, Khan KS, Zamora J, Malick S, Morley D, Pollard D, Ashcroft T, Popovic C, Sayers J.

Med Teach. 2009 Apr;31(4):282-98. doi: 10.1080/01421590902889897. Review.

PMID:
19404891
19.

Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.

Ballard JL, Weaver FA, Singla NK, Chapman WC, Alexander WA.

J Am Coll Surg. 2010 Feb;210(2):199-204. doi: 10.1016/j.jamcollsurg.2009.09.042. Epub 2009 Dec 14.

PMID:
20113940
20.

Use of histamine2-antagonists for the treatment of verruca vulgaris.

Fit KE, Williams PC.

Ann Pharmacother. 2007 Jul;41(7):1222-6. Epub 2007 May 29. Review.

PMID:
17535844

Supplemental Content

Support Center